Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma.
MicroRNA (miRNA)-based therapies are an emerging class of targeted therapeutics with many potential applications. Ewing Sarcoma patients could benefit dramatically from personalized miRNA therapy due to inter-patient heterogeneity and a lack of druggable (to this point) targets. However, because of...
Guardado en:
Autores principales: | Davis T Weaver, Kathleen I Pishas, Drew Williamson, Jessica Scarborough, Stephen L Lessnick, Andrew Dhawan, Jacob G Scott |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d3d3a5fa7c66497d85ed284850f43e42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.
por: Elizabeth T Wiles, et al.
Publicado: (2013) -
MEDICAL TREATMENT IN EWING SARCOMA
por: Roberto Luksch
Publicado: (2021) -
NPM1 is a Novel Therapeutic Target and Prognostic Biomarker for Ewing Sarcoma
por: Yangfan Zhou, et al.
Publicado: (2021) -
Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility
por: Mitchell J. Machiela, et al.
Publicado: (2018) -
Unusual Complication of Ewing Sarcoma of Vulva: Case Report
por: Masoud Khalil, et al.
Publicado: (2020)